Tag: Biocon
Biocon’s Q4 Results: Profit Jumps 154% YoY to ₹344 Crore on Strong Performance
Biocon's profit for the fourth quarter (Q4) of the financial year 2025 has increased by 154% compared to…
Biocon Sees 3.10% Jump After Securing U.S. Deal for Yesafili Biosimilar—Is This a Game Changer?
Biocon, a global leader in biopharmaceuticals, is making waves in the ophthalmology field with the launch of Yesafili,…
Biocon FDA Approval JOBEVNE Biosimilar Could Rewrite Cancer Care Costs
Biocon FDA Approval for JOBEVNE Biosimilar Marks a Big Win in Cancer Care Biocon Biologics has received U.S.…
Great News! Biocon’s new blood pressure injection gets US FDA approval Know how this could help patients!
Biocon Ltd., a well-known biopharmaceutical company, has received approval from the US FDA for its norepinephrine bitartrate injection.…